Witryna(1) Introduction: Small cell lung cancer (SCLC) is an aggressive tumor type, accounting for about 15% of all lung cancers. Radiotherapy (RT) plays a fundamental role in both early and advanced stages. Currently, in advanced disease, the use of consolidative chest RT should be recommended for patients with good response to platinum-based … Witryna5 gru 2024 · The aim of this study was to evaluate the cost-effectiveness of atezolizumab plus chemotherapy in treatment of extensive SCLC as first line in China. Methods: Utility values were obtained from published studies, and the costs were acquired from real world and literature.
First-line atezolizumab plus chemotherapy in treatment of …
Witryna25 wrz 2024 · The IMpower133 trial evaluated the efficacy and safety of adding atezolizumab or placebo to first-line treatment with carboplatin and etoposide in … Explore a collection of articles and other resources on the Coronavirus (Covid … Witryna17 gru 2024 · IMpower133 was a randomized, double-blind, placebo-controlled phase 3 trial for patients with treatment-naїve extensive-stage small cell. Over 400 patients … prime day macbook
Small cell lung cancer enters the era of precision medicine
Witryna1 lis 2024 · Atezolizumab in IMpower 133 and durvalumab in CASPIAN both improved survival when added to first-line chemotherapy in SCLC, leading to the approval of both agents and their current status as new standards of care [22,24].There are many differences between these two trials ().IMpower 133 was a double-blind, placebo … Witryna7 mar 2024 · Tecentriq as monotherapy is indicated for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have a PD-L1 expression ≥ 50% tumour cells (TC) or ≥ 10% tumour-infiltrating immune cells (IC) and who do not have EGFR mutant or ALK-positive NSCLC (see section 5.1). Witryna1 maj 2024 · For the past several decades, first-line therapy for extensive stage small-cell lung cancer (ES-SCLC) has been platinum-based chemotherapy (cisplatin or carboplatin) combined with etoposide. 1 Recent studies indicated that several immune checkpoint inhibitors (ICIs) were active in refractory SCLC. Subsequently, a phase III randomized … playing a harmonica beginners